Mobilized Leukopaks

CGT Global Mobilized Leukopaks are collected from healthy IRB consented donors that are injected with Granulocyte-Colony Stimulating Factor (G-CSF), Plerixafor, or a combination of Plerixafor and G-CSF, which increases circulating leukocytes and stimulates the bone marrow to produce a large number of hematopoietic and progenitor stem cells and mobilizes these cells into the bloodstream, allowing for enriched CD34+ hematopoietic stem cells from a single donor as compared to traditional Leukopaks. Collecting CD34+ stem cells from a single donor eliminates donor-to-donor variation, allows scalability of stem cell studies, and decreases same cell variability. Mobilized Leukopaks are ideal for stem cell studies relating to regenerative medicine, immunotherapy, and transplant therapy.

CGT Global Mobilized Leukopaks are collected in CLIA Certified clinics registered by the FDA.